In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure

Abdelrhman Abumoawad, Ahmed Saad, Christopher M. Ferguson, Alfonso Eirin, Sandra M. Herrmann, La Tonya J. Hickson, Busra B. Goksu, Emily Bendel, Sanjay Misra, James Glockner, Allan B. Dietz, Lilach O. Lerman, Stephen C. Textor

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure'. Together they form a unique fingerprint.

Medicine & Life Sciences